632 filings
8-K
APDN
Applied Dna Sciences Inc
19 Apr 24
Entry into a Material Definitive Agreement
4:15pm
8-K
APDN
Applied Dna Sciences Inc
16 Apr 24
Submission of Matters to a Vote of Security Holders
4:15pm
EFFECT
APDN
Applied Dna Sciences Inc
21 Mar 24
Notice of effectiveness
12:15am
424B3
APDN
Applied Dna Sciences Inc
20 Mar 24
Prospectus supplement
5:00pm
S-1/A
APDN
Applied Dna Sciences Inc
IPO registration (amended)
15 Mar 24
4:58pm
DEFA14A
0fjx 7t1zvb92nwj11x5
14 Mar 24
Additional proxy soliciting materials
5:51pm
D
opquk3
12 Feb 24
$6.87 mm in equity / options / securities to be acquired, 3 investors
4:09pm
8-K
krxna88mfu6
8 Feb 24
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
4:05pm
424B5
9b9 9prlfwa
1 Feb 24
Prospectus supplement for primary offering
4:05pm
8-K
k0b9syfr1eo2wr qlg3a
1 Feb 24
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
12:00am
8-K
nlujvlx
30 Jan 24
Termination of a Material Definitive Agreement
9:21pm
8-K
wvtssu hhuum
8 Jan 24
Regulation FD Disclosure
7:00am
8-K
qozlpj20s57rsgyam
5 Jan 24
Departure of Directors or Certain Officers
4:30pm
8-K
39suhb 93
7 Dec 23
Applied DNA Announces Fourth Quarter Fiscal Year 2023
4:05pm